Skip to main content

Table 5 Prediction of starting RRT (Females)

From: BMI and its association with death and the initiation of renal replacement therapy (RRT) in a cohort of patients with chronic kidney disease (CKD)

Variables

HRs

95% CI

 

p

BMI categories

 Normal BMI

Reference group

   

 Overweight

0.88

0.44

1.76

0.727

 Mild obesity

0.94

0.47

1.88

0.862

 Moderate obesity+

0.65

0.33

1.29

0.219

 Age > =68 years

0.19

0.10

0.37

< 0.001

CKD stage

 Stage 1 + 2

Reference group

   

 Stage 3A + 3B

3.35

0.37

30.42

0.283

 Stage 4 + 5

62.27

8.44

459.66

< 0.001

Primary renal diagnoses

 Glomerulonephritis

Reference group

   

 Genetic renal disease

1.28

0.48

3.37

0.622

 Diabetic nephropathy

2.47

0.86

7.09

0.092

 Renovascular disease

0.96

0.36

2.59

0.938

 Cancer

0.98

0.47

2.04

0.953

 Diabetes

0.52

0.24

1.14

0.102

 PVD

0.81

0.33

1.95

0.635

 Chronic lung disease

1.30

0.70

2.40

0.412

 CAD

0.65

0.29

1.43

0.280

 All other CVD

0.96

0.53

1.73

0.890

IRSD quintiles

 Lowest

Reference group

   

 Low

0.87

0.40

1.90

0.733

 Middle

0.72

0.36

1.44

0.351

 High

1.01

0.50

2.05

0.969

 Highest

1.27

0.48

3.41

0.630

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us